[PERSON]
Silviu Itescu
Featured in 1 tracked story · first seen
Situations
Mesoblast Ryoncil commercial development
2 clusters · 4 sources · last updated
Latest: Mesoblast reports 44% revenue surge in Ryoncil sales for Q1 FY26
Mesoblast Limited has achieved regulatory and financial milestones regarding its Ryoncil product, an FDA-approved mesenchymal stromal cell therapy for steroid-refractory acute graft versus host disease. In late Septembe